Literature DB >> 35585379

Kelch-like protein 3 in human disease and therapy.

Yan Lin1,2, Qian Li1,2, Xiaofeng Jin3,4.   

Abstract

Kelch-like protein 3 (KLHL3) is a substrate adaptor of Cullin3-RING ubiquitin ligase (CRL3), and KLHL3-CUL3 complex plays a vital role in the ubiquitination of specific substrates. Mutations and abnormal post-translational modifications of KLHL3-CUL3 affect substrate ubiquitination and may related to the pathogenesis of Gordon syndrome (GS), Primary Hyperparathyroidism (PHPT), Diabetes Mellitus (DM), Congenital Heart Disease (CHD), Pre-eclampsia (PE) and even cancers. Therefore, it is essential to understand the function and molecular mechanisms of KLHL3-CUL3 for the treatment of related diseases. In this review, we summary the structure and function of KLHL3-CUL3, the effect of KLHL3-CUL3 mutations and aberrant modifications in GS, PHPT, DM, CHD and PE. Moreover, we noted a possible role of KLHL3-CUL3 in carcinogenesis and provided ideas for targeting KLHL3-CUL3 for related disease treatment.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  CUL3; GS; KLHL3; Mutation; Ubiquitination

Mesh:

Substances:

Year:  2022        PMID: 35585379     DOI: 10.1007/s11033-022-07487-x

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.742


  79 in total

Review 1.  Ubiquitylation at the crossroads of development and disease.

Authors:  Michael Rape
Journal:  Nat Rev Mol Cell Biol       Date:  2017-09-20       Impact factor: 94.444

Review 2.  Protein Modification and Autophagy Activation.

Authors:  Rui Wang; Guanghui Wang
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

3.  KLHL2 interacts with and ubiquitinates WNK kinases.

Authors:  Daiei Takahashi; Takayasu Mori; Mai Wakabayashi; Yutaro Mori; Koichiro Susa; Moko Zeniya; Eisei Sohara; Tatemitsu Rai; Sei Sasaki; Shinichi Uchida
Journal:  Biochem Biophys Res Commun       Date:  2013-07-06       Impact factor: 3.575

Review 4.  MDM2 inhibition: an important step forward in cancer therapy.

Authors:  Marina Konopleva; Giovanni Martinelli; Naval Daver; Cristina Papayannidis; Andrew Wei; Brian Higgins; Marion Ott; John Mascarenhas; Michael Andreeff
Journal:  Leukemia       Date:  2020-07-10       Impact factor: 11.528

Review 5.  CRL3s: The BTB-CUL3-RING E3 Ubiquitin Ligases.

Authors:  Pu Wang; Junbin Song; Dan Ye
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

6.  Targeting Cul3-scaffold E3 ligase complex via KLHL substrate adaptors for cancer therapy.

Authors:  Senfeng Xiang; Xiaoxian Shi; Pengfei Chen; Yifan Chen; Shaowei Bing; Xizhi Jin; Ji Cao; Jinhu Wang; Bo Yang; Xuejing Shao; Qiaojun He; Meidan Ying
Journal:  Pharmacol Res       Date:  2021-04-17       Impact factor: 7.658

7.  The Keap1-Nrf2 system in cancers: stress response and anabolic metabolism.

Authors:  Yoichiro Mitsuishi; Hozumi Motohashi; Masayuki Yamamoto
Journal:  Front Oncol       Date:  2012-12-26       Impact factor: 6.244

8.  Calcineurin dephosphorylates Kelch-like 3, reversing phosphorylation by angiotensin II and regulating renal electrolyte handling.

Authors:  Kenichi Ishizawa; Qin Wang; Jinping Li; Osamu Yamazaki; Yoshifuru Tamura; Yoshihide Fujigaki; Shunya Uchida; Richard P Lifton; Shigeru Shibata
Journal:  Proc Natl Acad Sci U S A       Date:  2019-02-04       Impact factor: 11.205

Review 9.  Targeting p53 for the treatment of cancer.

Authors:  Michael J Duffy; Naoise C Synnott; Shane O'Grady; John Crown
Journal:  Semin Cancer Biol       Date:  2020-07-31       Impact factor: 15.707

10.  Update on the Kelch-like (KLHL) gene family.

Authors:  Bajinder S Dhanoa; Tiziana Cogliati; Akhila G Satish; Elspeth A Bruford; James S Friedman
Journal:  Hum Genomics       Date:  2013-05-15       Impact factor: 4.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.